Skip to main content
Livermore
Livermore
ZHEN

HM Payson & Co

SEC CIK
0000928052
Latest filing
Jul 17, 2026

EW holding history

Edwards Lifesciences Corp in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EW overviewAll 13F holders of EWFull Q2 2026 holdings

Shares (Q2 2026)
6,621
Value
$598.9K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of EW by HM Payson & Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266,621$598.9K<0.1%00.0%UnchangedHolders
Q1 20266,621$530.2K<0.1%00.0%UnchangedHolders
Q4 20256,621$564.4K<0.1%−100−1.5%ReducedHolders
Q3 20256,721$522.7K<0.1%00.0%UnchangedHolders
Q2 20256,721$525.6K<0.1%−400−5.6%ReducedHolders
Q1 20257,121$516.1K<0.1%+200+2.9%AddedHolders
Q4 20246,921$512.4K<0.1%−312−4.3%ReducedHolders
Q3 20247,233$477.3K<0.1%+1,128+18.5%AddedHolders
Q2 20246,105$563.9K<0.1%+22+0.4%AddedHolders
Q1 20246,083$581.3K<0.1%00.0%UnchangedHolders
Q4 20236,083$463.8K<0.1%+125+2.1%AddedHolders
Q3 20235,958$412.8K<0.1%+2,040+52.1%AddedHolders
Q2 20233,918$369.6K<0.1%−240−5.8%ReducedHolders
Q1 20234,158$344.0K<0.1%−1,276−23.5%ReducedHolders
Q4 20225,434$405.4K<0.1%+567+11.6%AddedHolders
Q3 20224,867$402.0K<0.1%−450−8.5%ReducedHolders
Q2 20225,317$506.0K<0.1%−14−0.3%ReducedHolders
Q1 20225,331$628.0K<0.1%+144+2.8%AddedHolders
Q4 20215,187$672.0K<0.1%−348−6.3%ReducedHolders
Q3 20215,535$627.0K<0.1%+1,198+27.6%AddedHolders
Q2 20214,337$449.0K<0.1%00.0%UnchangedHolders
Q1 20214,337$363.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.